Skip to content

Strategy for Prompt and Effective Thoracentesis in the Emergency Department

Strategy for Prompt and Effective Thoracentesis in the Emergency Department: A Multicenter Randomized Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06180603
Acronym
SPEEDTAP
Enrollment
188
Registered
2023-12-22
Start date
2024-01-15
Completion date
2025-12-31
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Pleural Diseases, Pleural Effusion

Keywords

Thoracentesis, Emergency department, Treatment methods

Brief summary

The SPEEDTAP-trial is a prospective, randomised, investigator-initiated, multicenter, clinical superior trial investigating two thoracentesis methods in four emergency departments (ED) in Central Denmark Region. Patients are randomised to either manual fluid removal in the ED or passively fluid drainage using gravity in the radiology department (standard of care). Primary outcome: time from clinical indication to complete drainage and 188 patients will be included. Key secondary outcomes include length of stay, ED admission to ED discharge and safety end-points.

Interventions

PROCEDUREManual drainage in the emergency department

Thoracentesis will be performed according to current guidelines in the emergency department. Fluid will manually be drained using a syringe connected to a three-way stopcock. Thoracentesis will be stopped early if:

PROCEDUREGravity fluid drainage in the radiology department

Patients will be referred to the radiology department. Thoracentesis will be performed according to local guidelines.

Sponsors

Central Denmark Region
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years admitted to the ED * Pleural effusion detected by any imaging modality (e.g., bedside ultrasound, chest x-ray, computed tomography) * Clinically justified need for thoracentesis ( symptomatic relief and/or define the etiology of the effusion * Without contraindication for thoracentesis in the emergency department (e.g., anticoagulant treatment)

Exclusion criteria

* Life-threatening respiratory distress * Not able to give consent * Previous pleurodesis * Effusion does not appear free-flowing due to septations or loculations / suspected empyema * Prior enrollment in the trial * If randomization is not possible because decision to insert a pigtail catheter is made in the radiology department

Design outcomes

Primary

MeasureTime frameDescription
Time from identification of the clinical indication for thoracentesis to complete drainageFrom date and time for randomization until the date and time removal of catheter, assessed up to 3 monthTime from identification of the clinical indication for thoracentesis is defined as the time patient is randomized. The time of complete drainage is defined by removal of pigtail catheter

Secondary

MeasureTime frameDescription
Duration of procedure (time)from date and time for insertion until date and time for removal, assessed up until 3 monthDefined as from date and time for insertion of catheter until date and time for removal of catheter
Patients degree of chest discomfort (score)from date of indication until removal of catheter, assessed up until 3 monthChest discomfort will be assessed using an appropiate scale before insertion of the catheter, during the procedure and after removal of catheter
Patients degree of breathlessnesss (score)from date of indication until removal of catheter, assessed up until 3 monthBreathlessness will be assessed using an appropiate scale before insertion of the catheter, during the procedure and after removal of catheter
Patients satisfactionOn the date of removal, assessed up until 1 monthAfter removal of catheter patients will be given a questionnaire
Hospital length of stay (days)Date of admission until date of hospital discharge, assessed up until 3 monthDefined as from date of admission until the date of hospital discharge
30 days re-admission (count)from date of discharge and up assessed until 30 daysdefined as any admission during 30 day follow-up
Complications to thoracentesis (count)from insertion of catheter and assessed up until 1 week after removal of catheterNumber of complications to thoracentesis
Total ED admission time (days)From date and time for admission until date and time for ED discharge, assessed up until 1 monthDate and time for admission until date and time for ED discharge
Total volume drained ( ml)from date of insertion of catheter until removal of catheter, assessed up until 3 monththe total amount of fluid drained from insertion of catether until removal of cathether
72- hour revisit from discharged (count)from date of discharge and up until 72 hoursDefined as any unplanned hospital stay within 72 hours from previous hospital discharge

Countries

Denmark

Contacts

Primary ContactSandra T Langsted
sandra.langsted@clin.au.dk+45 20 27 65 12
Backup ContactBo Løfgren
bl@clin.au.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026